Loading organizations...
Loading organizations...
Advancing immune-driven medicine for disease diagnosis and treatment.
Adaptive Biotechnologies has raised $414.8M across 5 funding rounds.
Key people at Adaptive Biotechnologies.
Adaptive Biotechnologies was founded by Harlan Robins (Head of Innovation, Co-founder) and Chad Robins (Co-Founder, President & CEO).
Adaptive Biotechnologies has raised $414.8M in total across 5 funding rounds.
Adaptive Biotechnologies was founded by Harlan Robins (Head of Innovation, Co-founder) and Chad Robins (Co-Founder, President & CEO).
Adaptive Biotechnologies has raised $414.8M in total across 5 funding rounds.
Adaptive Biotechnologies's investors include David Goel, Viking Global Investors.
Key people at Adaptive Biotechnologies.
Adaptive Biotechnologies has raised $414.8M across 5 funding rounds. Most recently, it raised $15.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 30, 2025 | $15.0M Series A | ||
| May 7, 2015 | $195.0M Series F | David Goel | |
| Jan 7, 2015 | $94.0M Other Equity | Viking Global Investors | |
| Apr 7, 2014 | $105.0M Series C / Series D | Viking Global Investors | |
| Jun 10, 2011 | $5.8M Series B |